<code id='19E256BF18'></code><style id='19E256BF18'></style>
    • <acronym id='19E256BF18'></acronym>
      <center id='19E256BF18'><center id='19E256BF18'><tfoot id='19E256BF18'></tfoot></center><abbr id='19E256BF18'><dir id='19E256BF18'><tfoot id='19E256BF18'></tfoot><noframes id='19E256BF18'>

    • <optgroup id='19E256BF18'><strike id='19E256BF18'><sup id='19E256BF18'></sup></strike><code id='19E256BF18'></code></optgroup>
        1. <b id='19E256BF18'><label id='19E256BF18'><select id='19E256BF18'><dt id='19E256BF18'><span id='19E256BF18'></span></dt></select></label></b><u id='19E256BF18'></u>
          <i id='19E256BF18'><strike id='19E256BF18'><tt id='19E256BF18'><pre id='19E256BF18'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          hotspot

          author:fashion    - browse:6988
          A gene-edited Yucatan minipig. -- health coverage from STAT
          A gene-edited Yucatan minipig created by eGenesis. Courtesy Liz Linder/eGenesis

          For three days in December, an ICU room at the Hospital of the University of Pennsylvania bore witness to the first-ever merging of two powerful new technologies poised to change the future of transplant medicine.

          On a gurney, a brain-dead patient lay connected to a whirring Rube Goldberg-esque machine: a tangle of tubes and siphons on wheels. From a cannula on one end, blood from the patient entered, was pumped full of oxygen and other nutrients, then pushed into a cozy, temperature-controlled chamber containing a liver — one that until very recently had belonged to a CRISPR-edited pig — before being returned to the patient.

          advertisement

          The experiment, designed to test whether a genetically engineered porcine liver kept alive in a box could support the circulatory system of a human, was a resounding success, the research team said Thursday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus